Vera Therapeutics (VERA) Competitors $42.31 -0.29 (-0.68%) (As of 05:27 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends VERA vs. QGEN, ITCI, ROIV, ASND, RVMD, LNTH, NUVL, LEGN, BPMC, and ELANShould you be buying Vera Therapeutics stock or one of its competitors? The main competitors of Vera Therapeutics include Qiagen (QGEN), Intra-Cellular Therapies (ITCI), Roivant Sciences (ROIV), Ascendis Pharma A/S (ASND), Revolution Medicines (RVMD), Lantheus (LNTH), Nuvalent (NUVL), Legend Biotech (LEGN), Blueprint Medicines (BPMC), and Elanco Animal Health (ELAN). These companies are all part of the "pharmaceutical products" industry. Vera Therapeutics vs. Qiagen Intra-Cellular Therapies Roivant Sciences Ascendis Pharma A/S Revolution Medicines Lantheus Nuvalent Legend Biotech Blueprint Medicines Elanco Animal Health Qiagen (NYSE:QGEN) and Vera Therapeutics (NASDAQ:VERA) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, earnings, community ranking, analyst recommendations, valuation and institutional ownership. Do analysts rate QGEN or VERA? Qiagen presently has a consensus price target of $51.88, suggesting a potential upside of 16.05%. Vera Therapeutics has a consensus price target of $59.22, suggesting a potential upside of 38.21%. Given Vera Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Vera Therapeutics is more favorable than Qiagen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Qiagen 0 Sell rating(s) 3 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.67Vera Therapeutics 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 3.10 Which has higher valuation and earnings, QGEN or VERA? Qiagen has higher revenue and earnings than Vera Therapeutics. Vera Therapeutics is trading at a lower price-to-earnings ratio than Qiagen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQiagen$1.97B5.19$341.30M$0.39114.62Vera TherapeuticsN/AN/A-$95.99M-$2.61-16.42 Does the media prefer QGEN or VERA? In the previous week, Vera Therapeutics had 3 more articles in the media than Qiagen. MarketBeat recorded 6 mentions for Vera Therapeutics and 3 mentions for Qiagen. Vera Therapeutics' average media sentiment score of 1.07 beat Qiagen's score of 0.44 indicating that Vera Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Qiagen 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Vera Therapeutics 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community believe in QGEN or VERA? Qiagen received 213 more outperform votes than Vera Therapeutics when rated by MarketBeat users. However, 63.16% of users gave Vera Therapeutics an outperform vote while only 60.88% of users gave Qiagen an outperform vote. CompanyUnderperformOutperformQiagenOutperform Votes24960.88% Underperform Votes16039.12% Vera TherapeuticsOutperform Votes3663.16% Underperform Votes2136.84% Do insiders & institutionals believe in QGEN or VERA? 70.0% of Qiagen shares are owned by institutional investors. Comparatively, 99.2% of Vera Therapeutics shares are owned by institutional investors. 9.0% of Qiagen shares are owned by insiders. Comparatively, 21.7% of Vera Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more volatility and risk, QGEN or VERA? Qiagen has a beta of 0.35, indicating that its share price is 65% less volatile than the S&P 500. Comparatively, Vera Therapeutics has a beta of 1.08, indicating that its share price is 8% more volatile than the S&P 500. Is QGEN or VERA more profitable? Qiagen has a net margin of 4.73% compared to Vera Therapeutics' net margin of 0.00%. Qiagen's return on equity of 13.43% beat Vera Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Qiagen4.73% 13.43% 8.10% Vera Therapeutics N/A -50.13%-39.50% SummaryVera Therapeutics beats Qiagen on 10 of the 18 factors compared between the two stocks. Ad WealthPress70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.>> You can grab your FREE, laminated copies right here << Get Vera Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VERA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VERA vs. The Competition Export to ExcelMetricVera TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.71B$6.61B$5.16B$9.10BDividend YieldN/A2.99%5.12%4.26%P/E Ratio-16.4210.6387.5117.12Price / SalesN/A194.281,136.45119.65Price / CashN/A57.1643.2337.85Price / Book22.095.104.784.77Net Income-$95.99M$151.83M$120.55M$225.50M7 Day Performance-2.53%-1.19%-1.64%-1.29%1 Month Performance-11.30%-4.73%14.04%0.45%1 Year Performance170.35%8.89%28.88%15.38% Vera Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VERAVera Therapeutics3.6233 of 5 stars$42.31-0.7%$59.22+40.0%+168.8%$2.68BN/A-16.2140Insider TradePositive NewsQGENQiagen3.6239 of 5 stars$45.49+0.2%$51.15+12.4%+0.3%$10.38B$1.97B117.035,967ITCIIntra-Cellular Therapies4.0661 of 5 stars$84.60+1.9%$97.23+14.9%+18.6%$8.97B$612.78M-95.91560Positive NewsROIVRoivant Sciences2.8671 of 5 stars$12.09+2.1%$17.93+48.3%+6.2%$8.80B$129.13M2.10860Insider TradeASNDAscendis Pharma A/S3.1225 of 5 stars$136.50+5.1%$191.77+40.5%+9.5%$8.28B$327.43M-16.52640RVMDRevolution Medicines4.4816 of 5 stars$44.90-0.2%$63.67+41.8%+61.5%$7.55B$11.58M-12.54443LNTHLantheus4.3811 of 5 stars$94.83+1.9%$130.00+37.1%+49.8%$6.59B$1.50B15.42834NUVLNuvalent2.1927 of 5 stars$86.56-0.3%$112.60+30.1%+15.2%$6.15BN/A-25.0340Positive NewsLEGNLegend Biotech1.5486 of 5 stars$33.25-5.3%$81.54+145.2%-43.0%$6.07B$520.18M-36.971,800BPMCBlueprint Medicines2.5415 of 5 stars$95.33+2.3%$122.11+28.1%+1.5%$6.06B$434.42M-45.28640Insider TradeELANElanco Animal Health3.6613 of 5 stars$12.18+0.7%$16.75+37.5%-20.7%$6.02B$4.45B30.259,300 Related Companies and Tools Related Companies Qiagen Competitors Intra-Cellular Therapies Competitors Roivant Sciences Competitors Ascendis Pharma A/S Competitors Revolution Medicines Competitors Lantheus Competitors Nuvalent Competitors Legend Biotech Competitors Blueprint Medicines Competitors Elanco Animal Health Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:VERA) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VERA Stock Alerts